This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Texas Students Win Regional Siemens Competition At The University Of Texas At Austin For Research On Cancer Therapy And Vaccine Development

"It's top-tier science. Frederick discovered what could be a very promising new approach to treating cancer by making human cells transgenic," said competition judges Dr. Janice Fischer, professor, and Dr. Blerta Xhemalce, assistant professor, both in Molecular Biosciences, The University of Texas at Austin. "He commands a breadth of knowledge in technique and tools that is impressive for a high school student. The sophistication of the approach and the science of his research could serve as a cornerstone publication in the field."

Inspired by his parents' work as physicians in a cancer center, Frederick similarly is keen to pursue a profession in biomedical research, or as an engineer allowing him to apply both math and science. He is a National Merit Scholar Semifinalist, and a member of the Junior States of America club. Additionally, he is captain of his school's varsity soccer team and a two-year participant and "lead teacher" in the school's annual community service trip to Costa Rica.

His mentor is Dr. Anwar Hossain, senior research scientist, MD Anderson Cancer Center, Department of Neurosurgery.

The Winning Team

Alyssa Chen, a junior at Highland Park High School in Dallas, Texas, and Shriya Das, a junior at The Hockaday School in Dallas, Texas, won the team category and will share a $6,000 scholarship for their project entitled, Encapsulation of c-di-GMP Adjuvant into pH-tunable Micelle-based Nanoparticle Heightens Immune Response.

In their research on vaccine development, Alyssa and Shriya merged the disciplines of nanotechnology and immunology to develop adjuvants, molecules that can boost immune responses.  By encapsulating the adjuvant, the team was able to increase its potency and facilitate its delivery directly into the immune cell. The team's discovery could have the potential to develop more vaccines for cancer and difficult-to-cure infectious diseases.

2 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 -1.15%
FB $117.58 0.73%
GOOG $693.01 0.29%
TSLA $240.76 -2.81%
YHOO $36.60 0.03%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs